The Long-Acting GLP-1 Derivative NN2211 Ameliorates Glycemia and Increases Β-Cell Mass in Diabetic Mice

American Journal of Physiology - Endocrinology and Metabolism- United States

doi 10.1152/ajpendo.00030.2002

Full Text

Abstract

Available in

Date

Authors

Publisher

American Physiological Society

Related search

Discovery of Novel and Long Acting GLP-1 Analogs

2015English

Impaired Pancreatic Growth, Β Cell Mass, and Β Cell Function in E2F1 –/– Mice

Journal of Clinical Investigation
Medicine
2004English

The Privileged Position of GLP-1 in Diabetic Nephropathy

Endocrinology&Metabolism International Journal
2018English

Metformin Ameliorates Insulitis in STZ-induced Diabetic Mice

PeerJ
GeneticsMolecular BiologyBiochemistryBiological SciencesMedicineAgriculturalNeuroscience
2017English

Adjuvant Immunotherapy Increases Cell Regenerative Factor Reg2 in the Pancreas of Diabetic Mice

Journal of Immunology
AllergyImmunology
2010English

Β-Arrestin-Biased Agonists of the GLP-1 Receptor From Β-Amino Acid Residue Incorporation Into GLP-1 Analogues

Journal of the American Chemical Society
BiochemistryColloidCatalysisChemistrySurface Chemistry
2016English

Curcumin Combined With Metformin Decreases Glycemia and Dyslipidemia, and Increases Paraoxonase Activity in Diabetic Rats

Diabetology and Metabolic Syndrome
Internal MedicineEndocrinologyMetabolismDiabetes
2019English

Chronic Exposure to GLP-1 Increases GLP-1 Synthesis and Release in a Pancreatic Alpha Cell Line (Α-Tc1): Evidence of a Direct Effect of GLP-1 on Pancreatic Alpha Cells

PLoS ONE
Multidisciplinary
2014English

Elovl6 Deficiency Improves Glycemic Control in Diabetic Db / Db Mice by Expanding Β-Cell Mass and Increasing Insulin Secretory Capacity

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy